Inhibrx Biosciences Investor Relations Material

Inhibrx Biosciences Inc. is a clinical-stage biotechnology company focused on developing biologic therapeutic candidates. The company's work is centered on leveraging its proprietary protein engineering platforms to design and develop therapies aimed at treating serious and life-threatening conditions. Inhibrx's pipeline includes multiple candidates that target various pathways involved in cancer and other critical diseases, with several programs in clinical trials. Inhibrx Biosciences is headquartered in La Jolla, California, and its shares are listed on the NASDAQ.